d.achebe
TL2 Moderator · Leuven
Contributes reviews on supplier material. Based in Leuven.
Joined 19 June 2025 · last posted 4d
92 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #32 · Start Here › Welcome · 24 Jul 2026 · 20 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #28 · Clinical › Bloodwork · 23 Jul 2026 · 13 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Retatrutide mass and identity: what a report should show Replied, post #21 · Compounds › Retatrutide · 19 Jul 2026 · 0 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Tracking intake honestly when appetite is absent Replied, post #101 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 22 likes I read post #99 twice before replying, because I had assumed the opposite. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…
-
Which categories are strict and which are relaxed, honestly Replied, post #12 · Start Here › Welcome · 13 Jul 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #22 · Start Here › Welcome · 8 Jul 2026 · 6 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Electrolyte supplements: which ones do anything Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2026 · 11 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #11 · Evidence › Journal club · 30 Jun 2026 · 17 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #10 · Practice › Side effects · 25 Jun 2026 · 5 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #53 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 27 likes This follows post #50 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #78 · Practice › Administration · 13 Jun 2026 · 0 likes Coming back to post #76, because the follow-up matters more than the original answer. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny…
-
[2026 update] What a good consultation looks like from the other side Replied, post #36 · Clinical › Prescriber conversations · 9 Jun 2026 · 3 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #40 · Analytics › Impurities & related substances · 8 Jun 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #15 · Outcomes › Progress reports · 7 Jun 2026 · 17 likes Coming back to post #13, because the follow-up matters more than the original answer. Exercise volume changes: increasing exercise intensity or duration can mask weight…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #38 · Practice › Storage & stability · 31 May 2026 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #17 · Access › Insurance & coverage · 26 May 2026 · 14 likes post #16 is right about the mechanism and I think understates the practical bit. Denial letters: the stated reason tells you exactly what to submit next. A denial is…
-
Naming conventions for research peptides and the confusion they cause Replied, post #5 · Compounds › Other compounds · 19 May 2026 · 4 likes post #4 is right about the mechanism and I think understates the practical bit. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #8 · Documentation › Doc review · 17 May 2026 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. New maintainer recruitment: if a page's maintainer is inactive and updates are needed,…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #116 · Compounds › Tirzepatide · 9 May 2026 · 0 likes This follows post #113 rather than contradicting it. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #95 · Devices › Syringes & needles · 7 May 2026 · 2 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #36 · Analytics › Impurities & related substances · 6 May 2026 · 17 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #21 · Safety › Contraindications · 27 Apr 2026 · 18 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #15 · Sourcing › Independent verification · 25 Apr 2026 · 24 likes I read post #13 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #2 · Practice › Reconstitution · 4 Apr 2026 · 26 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #42 · Research Methods › N-of-1 designs · 7 Mar 2026 · 16 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Measurement error in a self-reported exposure Replied, post #114 · Evidence › Study critique · 27 Feb 2026 · 19 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #92 · Pharmacology › Pharmacokinetics · 25 Feb 2026 · 0 likes I read post #90 twice before replying, because I had assumed the opposite. Renal clearance: these compounds are cleared partly via the kidney. In severe renal…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #81 · Meta › Site feedback · 24 Feb 2026 · 0 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Five questions in one post gets you one answer — how to split them Replied, post #18 · Start Here › How to Ask · 23 Feb 2026 · 4 likes Picking up post #15: that is the part I would want checked first. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #47 · Pharmacology › Pharmacokinetics · 19 Feb 2026 · 0 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Trifluoroacetate content and its consequences Replied, post #124 · Analytics › Impurities & related substances · 10 Feb 2026 · 1 like Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
[2026 update] What a purity-only report leaves out Replied, post #10 · Sourcing › Independent verification · 28 Jan 2026 · 13 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #18 · Start Here › Welcome · 27 Jan 2026 · 28 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Coverage in the US: a map of the usual obstacles Replied, post #38 · Regional › North America · 18 Jan 2026 · 12 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Reporting a good result: why nobody bothers and why they should Started this topic · Sourcing › Vendor reports · 14 Jan 2026 · 19 likes Reporting a good result: why nobody bothers and why they should — setting out what I have, and where I think it stops being reliable. Structured report rather than an…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #80 · Sourcing › Independent verification · 14 Jan 2026 · 21 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Heterogeneity as information rather than as a nuisance Replied, post #55 · Evidence › Meta-analyses · 9 Jan 2026 · 32 likes I read post #53 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Early satiety becoming a problem rather than a benefit Replied, post #23 · Practice › Side effects · 7 Jan 2026 · 4 likes Worth separating two things that post #19 runs together. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #22 · Compounds › Retatrutide · 10 Dec 2025 · 0 likes Worth separating two things that post #18 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #33 · Compounds › Tirzepatide · 4 Dec 2025 · 26 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Documentation that appears only after payment Replied, post #88 · Sourcing › Red flags · 26 Nov 2025 · 12 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Temperature loggers worth the money — the long version Replied, post #80 · Devices › Cold chain · 24 Nov 2025 · 17 likes Picking up post #77: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #105 · Practice › Reconstitution · 23 Nov 2025 · 0 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Sleep quality changes during weight loss — what changed since Replied, post #48 · Wellbeing › Sleep · 2 Nov 2025 · 7 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #17 · Analytics › Impurities & related substances · 28 Oct 2025 · 13 likes Worth separating two things that post #13 runs together. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #16 · Compounds › Tirzepatide · 21 Oct 2025 · 25 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Personal import allowances, compared — a second dataset Replied, post #11 · Access › International · 18 Oct 2025 · 16 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #7 · Analytics › Method validation · 17 Oct 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #83 · Practice › Storage & stability · 14 Oct 2025 · 15 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #128 · Practice › Storage & stability · 1 Sep 2025 · 9 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #66 · Clinical › Special populations · 23 Aug 2025 · 5 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #29 · Evidence › Preprints · 20 Aug 2025 · 1 like Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #85 · Outcomes › Progress reports · 25 Jul 2025 · 0 likes post #84 answers the question as asked. The question underneath it is different. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #72 · Clinical › Comorbidities · 15 Jul 2025 · 3 likes post #71 is right about the mechanism and I think understates the practical bit. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea…
-
Thyroid function tests during substantial weight change Replied, post #4 · Clinical › Bloodwork · 11 Jul 2025 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #59 · Compounds › Semaglutide · 7 Jul 2025 · 16 likes post #58 is right about the mechanism and I think understates the practical bit. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
Counter-ion content and its effect on measured mass Replied, post #76 · Analytics › Mass spectrometry · 27 Jun 2025 · 3 likes Picking up post #73: that is the part I would want checked first. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #58 · Pharmacology › Pharmacokinetics · 21 Jun 2025 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #59 · Evidence › Journal club · 18 Jun 2025 · 31 likes Worth separating two things that post #55 runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #9 · Compounds › Oral incretins · 14 Jun 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Sequence verification for an obscure compound: how it is done Replied, post #44 · Compounds › Other compounds · 25 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reverting an edit that had no revision note Replied, post #6 · Meta › Wiki maintenance · 24 May 2025 · 4 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Which panel is worth repeating and which is worth ignoring Replied, post #23 · Clinical › Bloodwork · 21 May 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #30 · Nutrition & Training › Protein & intake · 20 May 2025 · 4 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Lean mass preservation: what the evidence supports Replied, post #18 · Outcomes › Body composition · 16 May 2025 · 3 likes I read post #16 twice before replying, because I had assumed the opposite. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and…
-
Water content on a certificate and why it changes the arithmetic Replied, post #21 · Analytics › COA interpretation · 14 May 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. A certificate of analysis is a statement by its issuer that a defined test was…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #111 · Evidence › Journal club · 22 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #89 · Devices › Cold chain · 21 Apr 2025 · 25 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #77 · Practice › Reconstitution · 12 Apr 2025 · 28 likes On post #73 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Reading an MS report that only gives you a single number Replied, post #47 · Analytics › Mass spectrometry · 7 Apr 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #68 · Documentation › Doc review · 21 Mar 2025 · 0 likes This follows post #65 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #67 · Sourcing › Vendor reports · 17 Mar 2025 · 2 likes Worth separating two things that post #63 runs together. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #30 · Analytics › Mass spectrometry · 9 Mar 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Distinguishing a deletion sequence by mass alone Replied, post #108 · Analytics › Mass spectrometry · 19 Feb 2025 · 21 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Scheduled maintenance and what will be unavailable Replied, post #46 · Meta › Announcements · 17 Feb 2025 · 10 likes Picking up post #43: that is the part I would want checked first. Archives: older announcements are archived by date. Checking archives is useful if you want to know…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #12 · Access › International · 25 Jan 2025 · 4 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Preparing for an appointment: one page, three questions Replied, post #5 · Clinical › Prescriber conversations · 20 Jan 2025 · 0 likes post #4 answers the question as asked. The question underneath it is different. Understanding stopping rules: what would prompt stopping the compound? Adverse effect,…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #12 · Data & Tools › Calculators · 12 Jan 2025 · 0 likes Picking up post #9: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A promotion I argued against, and why I lost Replied, post #58 · Documentation › Doc review · 11 Jan 2025 · 2 likes post #57 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Oxidation pathways for methionine and tryptophan Replied, post #35 · Analytics › Impurities & related substances · 28 Dec 2024 · 9 likes Worth separating two things that post #31 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Washout with a one-week half-life: the arithmetic Replied, post #52 · Research Methods › N-of-1 designs · 2 Dec 2024 · 1 like Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #2 · Regional › UK & Ireland · 24 Nov 2024 · 8 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Identical chromatograms across two different lots Replied, post #51 · Sourcing › Red flags · 19 Nov 2024 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Reading a supplementary appendix and finding the interesting part Replied, post #19 · Evidence › Trials · 7 Nov 2024 · 1 like Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Time to steady state after a dose increase Replied, post #25 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 15 likes post #24 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #79 · Clinical › Prescriber conversations · 17 Oct 2024 · 5 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Signs of dehydration worth acting on Replied, post #30 · Safety › Adverse events · 16 Oct 2024 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Why the cheapest option is often not the cheapest Started this topic · Access › Pricing · 13 Oct 2024 · 14 likes Why the cheapest option is often not the cheapest — that is the question, and I have not found it answered plainly anywhere I have looked. Documenting an access…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #24 · Clinical › Comorbidities · 7 Oct 2024 · 13 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #7 · Analytics › Home & field testing · 19 Sep 2024 · 9 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #62 · Sourcing › Independent verification · 16 Sep 2024 · 8 likes Coming back to post #60, because the follow-up matters more than the original answer. Service differences on vendor pages: Janoshik and Medutest results are…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #18 · Evidence › Preprints · 21 Jul 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…